Structures by: Sreenivasa S.
Total: 55
3-[6-(4-Methoxyphenyl)-2-methylpyrimidin-4-yl]-2-(4-methylpiperazin-1-yl)quinoline
C26H27N5O
IUCrData (2018) 3, 1 x180030
a=11.9896(9)Å b=18.4215(13)Å c=10.9903(10)Å
α=90° β=110.153(9)° γ=90°
Ethyl (6-hydroxy-1-benzofuran-3-yl)acetate sesquihydrate
C12H12O4,1.5(H2O)
Acta Crystallographica Section E (2014) 70, 12 541-543
a=29.191(6)Å b=7.3291(17)Å c=12.587(3)Å
α=90.00° β=113.074(13)° γ=90.00°
Bis(4-methoxyphenyl) malonate
C17H16O6
Acta Crystallographica Section E (2015) 71, 5 o330-o331
a=5.4307(19)Å b=8.131(3)Å c=36.149(10)Å
α=90° β=90° γ=90°
2-Chloro-<i>N</i>-(3-fluorophenyl)acetamide
C8H7ClFNO
Acta Crystallographica Section E (2015) 71, 5 o315
a=5.0441(2)Å b=18.2374(7)Å c=8.8653(3)Å
α=90.00° β=99.8430(10)° γ=90.00°
4-Bromophenyl-2-oxo-2<i>H</i>-chromene-3-carboxylate
C16H9BrO4
Acta Crystallographica Section E (2015) 71, 5 o326-o327
a=16.0782(10)Å b=7.2618(4)Å c=12.7396(8)Å
α=90° β=113.311(4)° γ=90°
4-Methoxyphenyl 2-oxo-2<i>H</i>-chromene-3-carboxylate
C17H12O5
Acta Crystallographica Section E (2015) 71, 6 o374-o375
a=6.2648(18)Å b=10.435(3)Å c=20.621(7)Å
α=90° β=90° γ=90°
(<i>R</i>)-6-Bromo-3,3-dimethyl-3',4'-dihydro-2'<i>H</i>-spiro[cyclohexane-\ 1,3'-1,2,4-benzothiadiazine] 1',1'-dioxide
C14H19BrN2O2S
Acta Crystallographica Section E (2014) 70, 11 359-361
a=6.4316(7)Å b=24.263(3)Å c=10.0829(13)Å
α=90.00° β=105.604(9)° γ=90.00°
2-(4-Methylpiperazin-1-yl)quinoline-3-carbaldehyde
C15H17N3O
Acta Crystallographica Section E (2015) 71, 11 o900-o901
a=12.3282(4)Å b=5.8935(2)Å c=18.9202(7)Å
α=90.00° β=103.591(2)° γ=90.00°
2,2,2-Tribromo-<i>N</i>-(2-fluorophenyl)acetamide
C8H5Br3FNO
Acta Crystallographica Section E (2015) 71, 9 1048-1053
a=6.1825(13)Å b=8.929(2)Å c=9.971(2)Å
α=85.858(8)° β=87.966(8)° γ=78.919(8)°
2,2,2-Tribromo-<i>N</i>-[3-(trifluoromethyl)phenyl]acetamide
C9H5Br3F3NO
Acta Crystallographica Section E (2015) 71, 9 1048-1053
a=11.3441(6)Å b=10.3047(6)Å c=20.6397(11)Å
α=90.00° β=90.00° γ=90.00°
2,2,2-Tribromo-<i>N</i>-(4-fluorophenyl)acetamide
C8H5Br3FNO
Acta Crystallographica Section E (2015) 71, 9 1048-1053
a=16.9830(9)Å b=6.1095(3)Å c=10.1508(6)Å
α=90.00° β=100.4850(10)° γ=90.00°
4-(Decyloxy)phenyl 2-oxo-7-trifluoromethyl-2<i>H</i>-chromene-3-carboxylate
C27H29F3O5
Acta Crystallographica Section E (2013) 69, 4 o621-o622
a=27.85(3)Å b=9.281(10)Å c=9.981(11)Å
α=90.00° β=94.849(18)° γ=90.00°
<i>tert</i>-Butyl 4-{5-[3-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-3-yl}piperazine-1-carboxylate
C18H21F3N4O4
Acta Crystallographica Section E (2013) 69, 5 o761
a=5.773(2)Å b=11.168(5)Å c=15.991(7)Å
α=96.092(16)° β=100.316(14)° γ=91.333(14)°
1-(3,4-Difluorobenzyl)-4-(4-methylphenylsulfonyl)piperazine
C18H20F2N2O2S
Acta Crystallographica Section E (2013) 69, 7 o1179
a=6.6680(2)Å b=36.0404(8)Å c=7.6093(2)Å
α=90.00° β=99.728(2)° γ=90.00°
1-(3,5-Difluorophenyl)-4,4,4-trifluorobutane-1,3-dione
C10H5F5O2
Acta Crystallographica Section E (2013) 69, 11 o1705
a=12.393(4)Å b=13.433(5)Å c=12.877(5)Å
α=90.00° β=112.49(2)° γ=90.00°
Ethyl (2<i>E</i>)-2-cyano-3-(4-methoxyphenyl)acrylate
C13H13NO3
Acta Crystallographica Section E (2013) 69, 11 o1610
a=8.4889(12)Å b=8.3552(16)Å c=17.143(3)Å
α=90.00° β=91.294(11)° γ=90.00°
4-Methoxy-<i>N</i>-(pyridin-4-ylmethyl)-3-(trifluoromethyl)benzamide monohydrate
C15H13F3N2O2,H2O
Acta Crystallographica Section E (2013) 69, 11 o1717-o1718
a=7.2687(13)Å b=7.8758(14)Å c=14.177(3)Å
α=104.071(10)° β=99.672(10)° γ=97.210(10)°
4-Methoxy-<i>N</i>-[(4-methylphenyl)sulfonyl]benzamide
C15H15NO4S
Acta Crystallographica Section E (2013) 69, 11 o1664-o1665
a=27.1686(16)Å b=27.1686(16)Å c=10.8594(6)Å
α=90.00° β=90.00° γ=120.00°
6-Chloro-<i>N</i>-(pyridin-4-ylmethyl)pyridine-3-sulfonamide
C11H10ClN3O2S
Acta Crystallographica Section E (2013) 69, 12 o1765
a=5.4140(6)Å b=18.172(2)Å c=12.9392(15)Å
α=90.00° β=92.388(6)° γ=90.00°
<i>N</i>-(4-Methylphenylsulfonyl)-3-nitrobenzamide
C14H12N2O5S
Acta Crystallographica Section E (2014) 70, 2 o191
a=4.9736(5)Å b=23.245(2)Å c=12.7197(11)Å
α=90.00° β=100.820(4)° γ=90.00°
1-Fluoro-4-[(<i>E</i>)-2-nitrovinyl]benzene
C8H6FNO2
Acta Crystallographica Section E (2014) 70, 2 o124
a=16.0965(14)Å b=4.8453(4)Å c=9.5538(9)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Methoxybenzoyl)benzenesulfonamide
C14H13NO4S
Acta Crystallographica Section E (2014) 70, 2 o192
a=5.3059(5)Å b=10.6343(10)Å c=11.9139(11)Å
α=89.792(3)° β=87.392(3)° γ=83.944(3)°
<i>N</i>-(3-Hydroxyphenyl)succinimide
C10H9NO3
Acta Crystallographica Section E (2014) 70, 9 o927
a=11.432(2)Å b=7.6567(14)Å c=10.115(2)Å
α=90.00° β=98.688(7)° γ=90.00°
<i>N</i>-Ethyl-2,2-dimethyl-<i>N</i>-(3-methylphenyl)propanamide
C14H21NO
Acta Crystallographica Section E (2014) 70, 2 o223
a=7.631(4)Å b=10.878(7)Å c=8.350(3)Å
α=90.00° β=105.60(2)° γ=90.00°
2-Chloro-<i>N</i>-(4-methoxybenzoyl)benzenesulfonamide
C14H12ClNO4S
Acta Crystallographica Section E (2014) 70, 2 o199
a=14.5293(19)Å b=10.6225(14)Å c=9.6918(14)Å
α=90.00° β=92.695(5)° γ=90.00°
<i>N</i>-(4-Methoxybenzoyl)-2-methylbenzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2014) 70, 2 o193
a=21.807(2)Å b=7.3521(8)Å c=18.602(2)Å
α=90.00° β=101.211(3)° γ=90.00°
(<i>E</i>)-<i>tert</i>-Butyl 4-(<i>N</i>'-hydroxycarbamimidoyl)piperazine-1-carboxylate
C10H20N4O3
Acta Crystallographica Section E (2012) 68, 12 o3347
a=8.1923(17)Å b=8.7859(16)Å c=9.714(2)Å
α=109.451(7)° β=99.540(7)° γ=96.474(7)°
Methyl 4-(trifluoromethyl)-1<i>H</i>-pyrrole-3-carboxylate
C7H6F3NO2
Acta Crystallographica Section E (2013) 69, 10 o1566
a=16.643(2)Å b=7.1118(10)Å c=6.9618(11)Å
α=90.00° β=98.903(7)° γ=90.00°
4-Methyl-2,6-bis(pyrrolidin-1-yl)pyrimidine
C13H20N4
Acta Crystallographica Section E (2012) 68, 12 o3440
a=6.344(3)Å b=8.766(4)Å c=12.056(6)Å
α=79.10(3)° β=86.05(3)° γ=85.72(3)°
Methyl 4-benzyloxy-2-hydroxybenzoate
C15H14O4
Acta Crystallographica Section E (2012) 68, 12 o3382
a=5.7731(10)Å b=7.9855(14)Å c=14.046(3)Å
α=89.490(6)° β=80.111(5)° γ=87.210(6)°
1-(2-Amino-6-methylpyrimidin-4-yl)-<i>N</i>,<i>N</i>-dimethylpiperidin- 4-aminium chloride
C12H22N5,Cl
Acta Crystallographica Section E (2012) 68, 12 o3371
a=24.7908(12)Å b=8.2419(4)Å c=13.8764(6)Å
α=90.00° β=91.968(2)° γ=90.00°
6-[4-Chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine
C13H8ClF4N
Acta Crystallographica Section E (2012) 68, 12 o3370
a=13.1813(7)Å b=4.5837(3)Å c=20.4448(11)Å
α=90° β=92.441(3)° γ=90°
(E)-3-chloro-N'-hydroxybenzamidine
C7H7ClN2O
Acta Crystallographica Section E (2012) 68, 12 o3402
a=5.0018(17)Å b=10.984(4)Å c=14.407(6)Å
α=74.000(12)° β=89.952(12)° γ=89.877(11)°
4-Nitrophenyl 4-hydroxy-3-methylbenzoate
C14H11NO5
Acta Crystallographica Section E (2012) 68, 12 o3490
a=42.313(6)Å b=8.0047(11)Å c=16.1078(18)Å
α=90.00° β=105.819(4)° γ=90.00°
2-[5-(2-Fluorophenyl)-3-isobutyl-1<i>H</i>-pyrazol-1-yl]benzoic acid
C20H19FN2O2
Acta Crystallographica Section E (2013) 69, 2 o176
a=9.7732(14)Å b=12.2671(16)Å c=15.257(2)Å
α=90.00° β=106.836(5)° γ=90.00°
4'-Cyanobiphenyl-4-yl 7-diethylamino-2-oxo-2<i>H</i>-chromene-3-carboxylate
C27H22N2O4
Acta Crystallographica Section E (2013) 69, 2 o266
a=9.652(3)Å b=10.252(4)Å c=11.121(4)Å
α=87.214(10)° β=86.358(10)° γ=84.348(11)°
(2,3-Difluorophenyl)(4-tosylpiperazin-1-yl)methanone
C18H18F2N2O3S
Acta Crystallographica Section E (2013) 69, 2 o185
a=17.0456(4)Å b=7.60260(10)Å c=15.5113(3)Å
α=90.00° β=113.5130(10)° γ=90.00°
4-(Octyloxy)phenyl 2-oxo-2<i>H</i>-chromene-3-carboxylate
C24H26O5
Acta Crystallographica Section E (2013) 69, 2 o212
a=14.464(3)Å b=6.7548(15)Å c=21.381(5)Å
α=90.00° β=91.663(8)° γ=90.00°
1-Tosyl-4-[2-(trifluoromethyl)benzyl]piperazine
C19H21F3N2O2S
Acta Crystallographica Section E (2013) 69, 2 o239
a=9.5044(3)Å b=9.8389(3)Å c=12.1473(4)Å
α=72.0360(10)° β=77.0240(10)° γ=62.3840(10)°
4-Methyl-6-(piperidin-1-yl)pyrimidin-2-amine
C10H16N4
Acta Crystallographica Section E (2013) 69, 2 o197
a=13.9605(4)Å b=8.7564(3)Å c=17.7055(6)Å
α=90.00° β=104.381(2)° γ=90.00°
5-Fluoroanthranilic acid
C7H6FNO2
Acta Crystallographica Section E (2013) 69, 3 o387
a=4.9346(2)Å b=11.7542(6)Å c=11.9727(5)Å
α=90.00° β=96.782(3)° γ=90.00°
(1<i>Z</i>)-1-(1-Benzofuran-2-yl)ethanone oxime
C10H9NO2
Acta Crystallographica Section E (2014) 70, 1 o40
a=9.5727(12)Å b=4.7303(8)Å c=18.756(2)Å
α=90.00° β=96.178(6)° γ=90.00°
2-(6-Hydroxy-1-benzofuran-3-yl)acetamide
C10H9NO3
Acta Crystallographica Section E (2014) 70, 1 o87
a=5.0939(3)Å b=9.3629(5)Å c=18.7422(10)Å
α=90.00° β=90.00° γ=90.00°
5-(3,5-Difluorophenyl)-1-(4-fluorophenyl)-3-trifluoromethyl-1<i>H</i>-pyrazole
C16H8F6N2
Acta Crystallographica Section E (2014) 70, 1 o19
a=7.2535(3)Å b=8.6686(4)Å c=11.7690(5)Å
α=70.9090(10)° β=80.1390(10)° γ=88.0770(10)°
<i>tert</i>-Butyl 2-{[5-(4-cyanophenyl)pyridin-3-yl]sulfonyl}acetate
C18H18N2O4S
Acta Crystallographica Section E (2014) 70, 4 o415
a=17.3871(7)Å b=12.5318(5)Å c=8.4297(3)Å
α=90.00° β=99.103(2)° γ=90.00°
<i>N</i>-(3-Methoxybenzoyl)-4-methylbenzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2013) 69, 8 o1263
a=9.2474(7)Å b=9.6660(6)Å c=9.8764(8)Å
α=70.268(6)° β=64.052(8)° γ=86.231(5)°
2-Chloro-<i>N</i>-(3-methoxybenzoyl)benzenesulfonamide
C14H12ClNO4S
Acta Crystallographica Section E (2013) 69, 8 o1215
a=7.5731(5)Å b=10.1861(5)Å c=10.3636(6)Å
α=94.945(4)° β=96.581(5)° γ=110.974(5)°
4-[4-(Heptyloxy)benzoyloxy]phenyl 2-oxo-7-trifluoromethyl-2<i>H</i>-chromene-3-carboxylate
C31H27F3O7
Acta Crystallographica Section E (2013) 69, 8 o1355-o1356
a=5.6810(3)Å b=16.036(2)Å c=16.2954(18)Å
α=68.940(12)° β=88.914(6)° γ=88.486(7)°
1-(2,4-Dichlorobenzyl)-4-[(4-methylphenyl)sulfonyl]piperazine
C18H20Cl2N2O2S
Acta Crystallographica Section E (2013) 69, 5 o782
a=28.2896(5)Å b=28.2896(5)Å c=13.3041(3)Å
α=90.00° β=90.00° γ=120.00°
<i>N</i>'-Hydroxypyridine-2-carboximidamide
C6H7N3O
Acta Crystallographica Section E (2013) 69, 7 o1180
a=21.367(5)Å b=4.6382(11)Å c=13.003(3)Å
α=90.00° β=105.468(12)° γ=90.00°
4-(4-Methylphenylsulfonyl)piperazin-1-ium trifluoroacetate
C11H17N2O2S,C2F3O2
Acta Crystallographica Section E (2013) 69, 7 o1112
a=7.8796(6)Å b=22.5891(15)Å c=9.4626(7)Å
α=90.00° β=110.446(3)° γ=90.00°
<i>N</i>-[(2-Chlorophenyl)sulfonyl]-3-nitrobenzamide
C13H9ClN2O5S
Acta Crystallographica Section E (2013) 69, 7 o1090
a=12.290(8)Å b=13.548(9)Å c=17.240(11)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(3-Methoxybenzoyl)-2-methylbenzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2013) 69, 8 o1232
a=26.713(5)Å b=7.3717(4)Å c=19.636(3)Å
α=90.00° β=131.21(3)° γ=90.00°
6-(4-Fluorophenyl)-3-phenyl-7<i>H</i>-1,2,4-triazolo[3,4-<i>b</i>][1,3,4]thiadiazine
C16H11FN4S
Acta Crystallographica Section E (2014) 70, 3 o375
a=15.088(2)Å b=13.464(2)Å c=7.0557(12)Å
α=90.00° β=91.076(3)° γ=90.00°
<i>N</i>-[(2-Chlorophenyl)sulfonyl]-2-methoxybenzamide
C14H12ClNO4S
Acta Crystallographica Section E (2013) 69, 11 o1716
a=8.0508(3)Å b=12.9487(4)Å c=14.1915(5)Å
α=83.897(2)° β=89.368(2)° γ=89.704(2)°